Ethical criteria in clinical research in developing countries: Is there a global standard?

Giornale Italiano di Medicina Tropicale

Volumn 15, Issue 1-4, 2010, Pages 1-8

  Ravinetto, R ^a   Mbonile, L ^b,c   White, N ^d  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^c Mbeya Referral Hospital Tanzania   (Tanzania)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Clinical research; Developing countries; Ethics; Standards

Indexed keywords

PLACEBO;

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DEVELOPING COUNTRY; EMERGENCY CARE; GOOD CLINICAL PRACTICE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; MISCONDUCT; PATIENT CARE; PRIVATE PRACTICE; PROFESSIONAL STANDARD; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; RESEARCH ETHICS; REVIEW; RISK BENEFIT ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 79851474459     PISSN: 03943445     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. ANGELL M. (1997). The Ethics of Clinical Research in the Third World. The New England Journal of Medicine, 337 (12): 847-849.
2. BHUTTA Z. (2004). Standards of care in research. British Medical Journal, 329:1114-1115.
3. CIOMS (2002). Council for International Organizations of Medical Sciences. International Ethical Guidelines for Biomedical Research Involving Human Subjects. CIOMS, Geneva. Available at: http://www.cioms.ch/frame- guidelines-nov-2002.htm. Accessed 29 June 2009.
4. GCP/WHO (2003). Good Clinical Practice Alliance - Europe, African Malaria Network Trust, and Special Programme for Research and Training in Tropical Diseases/World Health Organization. Draft Reference Standard Operating Procedures for Ethics Committees Reviewing Health Research. Brussels, Entebbe, Geneva.
5. GLOBAL FORUM FOR HEALTH RESEARCH (2004). The 10/90 Report on Health Research 2003-2004. Geneva, Switzerland: Global Forum for Health Research.
6. GOODYEAR M.D.E., LEMMENS T., SPRUMONT D., TANGWA G. (2009). Does the FDA have the authority to trump the Declaration of Helsinki? British Medical Journal, 338: b1559.
7. HYDER A.A., WALI S.A., KHAN A.N., TEOH N.B., KASS N.E., DAWSON L. (2004). Ethical review of health research: a perspective from developing country researchers. Journal of Medical Ethics, 30: 68-72.
8. th June 1996.
9. KIMMELMAN J., WEIJER C., MESLIN E.M. (2009). Helsinki discords: FDA, ethics, and international drug trials. The Lancet, 373(9675): 13-14.
10. LIE R.K., EMANUEL E., GRADY C., WENDLER D. (2004). The standard of care debate: the Declaration of Helsinki versus the international consensus opinion. Journal of Medical Ethics, 30: 190-193.
11. LOUWENBERG S. (2008). Drug company trials come under increasing scrutiny. The Lancet, 371: 191-192.
12. LURIE P., WOLFE S.M. (1997). Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. The New England Journal of Medicine, 337: 853-6.
13. MILFORD C., WASSENAAR D., SLACK C. (2006). Resources and needs of research Ethics committees in Africa: Preparations for HIV vaccine trials. IRB: Ethics & Human Research, 28(2): 1-9.
14. ONDER R. (2005). The ethics of placebo controlled trials: The case of asthma. Journal of Allergy and Clinical Immunology, 115(6): 1228-34.
15. PRIOTTO G., PINOGES L., FURSA I.B., BURKE B., NICOLAY N. GRILLET G., HEWISON C., BALASEGARAM M. (2008). Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study. British Medical Journal, 336(7646): 705.
16. PRIOTTO G., KASPARIAN S., MUTOMBO W., NGOUAMA D., GHORASHIAN S., ARNOLD U., GHABRI S., BAUDIN E., BUARD V., KAZADIKYANZA S., ILUNGA M., MUTANGALA W., POHLIG G., SCHMID C., KARUNAKARA U., TORREELE E., KANDE V. (2009). Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. The Lancet, 374(9683): 56-64.
17. REED H. (2002). Roundtable on the Demography of Forced Migration, National Research Council Research Ethics in Complex Humanitarian Emergencies: Summary of a Workshop. Available at http://www.nap.edu/catalog.php?record-id- 10481.
18. REHNQUIST J. (2001). The globalization of Clinical Trials: a growing challenge in protecting human subjects. Department of Health and Human Services, Office of Inspector General. OEI-01-00-00190, September 2001. 51 pp
19. SHAPIRO K., BENATAR S.R. (2005). HIV prevention research and global inequality: steps towards improved standards of care. Journal of Medical Ethics, 31: 39-47.
20. SCHIPPER I., WEYZIG F. (2008). Ethics for Drug Testing in Low and Middle Income Countries: Considerations for European Market Authorisation. SOMO, The Netherland. Available at: www.somo.nl.
21. SCHIPPER I., WEYZIG F. (2008a). Examples of unethical trials. SOMO briefing paper on ethics in clinical trials. SOMO, The Netherland. Available at: www.somo.nl.
22. SCHOPPER D., UPSHUR R., MATTHYS F., SINGH J.A., BANDEWAR S.S., AHMAD A., VAN DONGEN E. (2009). Research Ethics Review in Humanitarian Contexts: The Experience of the Independent Ethics Review Board of Médecins Sans Frontières. PLos Medicine, 6(7): 1-6.
23. STEWART P., STEARS A., TOMLISON J.W., BROWN M.J. (2008). Regulation: the real threat to clinical research. British Medical Journal, 337(7678): 1085-1087.
24. TDR/WHO (2000). Special Programme for Research and Training in Tropical Diseases/World Health Organization. Operational Guidelines for Ethics Committees That Review Biomedical Research. TDR WHO, Geneva.
25. th February 2003.
26. THE PLOs MEDICINE EDITORS (2009). Ethics without Borders. PLoS Medicine, 6(7): e1000119.
27. WEMOS (2008). A bitter pill: The risks of carrying out clinical drug trials in developing countries. Wemos, The Netherlands. Available at: www.wemos.nl.
28. WEMOS AND EUROPEAN PARLIAMENT (2007). Final report of the expert meeting: "Clinical trials and protection of trial subjects in low income and developing countries". December 2007.
29. WENDLER D., EMANUEL E.J., LIE R.K. (2004). The Standard of Care Debate: Can Research in Developing Countries Be Both Ethical and Responsive to Those Countries' Health Needs? American Journal of Public Health, 94: 923-928.
30. WHITE N. (2006). Editorial: Clinical trials in tropical diseases: a politically incorrect view. Tropical Medicine and International Health, 11(10): 1483-1484.
31. WORLD HEALTH ORGANIZATION (1995). Guidelines for GCP for trials on pharmaceutical products. Technical Report Series No. 850, Annex 3. WHO, Geneva.
32. WORLD HEALTH ORGANIZATION (2002). Handbook for Good Clinical Research Practices: Guidance for implementation. WHO, Geneva.
33. th WMA General Assembly, Seoul, October 2008. Available: http//www.wma.net/e/policy/b3.htm
34. ZWI A.B., GROVE N.J., MACKENZIE C., PITTAWAY E., ZION D., SILOVE D., TARANTOLA D. (2006). Placing ethics in the centre: Negotiating new spaces for ethical research in conflict situations. Global Public Health, 1(3): 264-277.